Invivyd - About the company
Invivyd is a public company based in Waltham (United States), founded in 2022. It operates as a Provider of drug research & development targets stem cell and clinical trial services. The company has 132 active competitors, including 27 funded and 13 that have exited. Its top competitors include companies like Blue Rock Therapeutics, CellCarta and Kincell Bio.
Company Details
- Website
- invivyd.com
- Social
Key Metrics
Founded Year
2022
Location
Waltham, United States
Stage
Public
Investors
Ranked
3rd among 132 active competitors
Annual Revenue
$50M - $100M as on Dec 31, 2025
Employee Count
179 as on Jun 30, 2026
Similar Companies
Exit Details
Public
Legal entities associated with Invivyd
Invivyd is associated with 2 legal entities given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
INVIVYD, INC. CIN: 215724196 , United States, Active | Aug 03, 2023 | - | - | - |
INVIVYD, INC. CIN: 1832038 , United States, Active | Jun 02, 2020 | $50M - $100M (As on Dec 31, 2025) | 86 (As on Dec 31, 2022) | - |
Invivyd's IPO details
Invivyd got listed on Aug 06, 2021.
Click here to take a look at Invivyd's IPO in detail
Sign up to download Invivyd's company profile
Invivyd's funding and investors
Invivyd is a funded company. Invivyd has 3 institutional investors.
View details of Invivyd's funding rounds and investors
Invivyd's founders and board of directors
Founder? Claim ProfileInvivyd's employee count trend
Invivyd has 179 employees as of Jun 26. Here is Invivyd's employee count trend over the years:
Uncover Invivyd's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Invivyd's Competitors and alternates
Top competitors of Invivyd include Blue Rock Therapeutics, CellCarta and Kincell Bio. Here is the list of Top 10 competitors of Invivyd, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st | Blue Rock Therapeutics 2016, Boston (United States), Acquired | Stem cell therapies for cardiovascular and neurological diseases | $225M | 62/100 | |
2nd | CRO focused on providing histopathology and genomics services | $7.5M | 59/100 | ||
3rd |  Invivyd 2022, Waltham (United States), Public | Provider of drug research & development targets stem cell and clinical trial services | - | 53/100 | |
4th |  Kincell Bio 2023, Gainesville (United States), Series A | Provider of clinical cell therapy development & manufacturing and consulting services | $58M | 48/100 | |
5th |  GC Green Cross Lab Cell 2008, Yongin si (South Korea), Funding Raised | Provider of research, development, and manufacturing services for cell & gene therapy products | - | - | 44/100 |
6th |  XDemics 2017, Monrovia (United States), Series B | CDMO focused on manufacturing cell & viral based therapeutics | $14.8M | - | 42/100 |
7th |  Impel Pharmaceuticals 2008, Seattle (United States), Acquired | Provider of trans-formative therapy development and commercialisation services | $67.5M | 41/100 | |
8th |  BioBridge Global 1974, San Antonio (United States), Unfunded | Manufacturer of cell and gene therapy clinical product & testing services | - | - | 39/100 |
9th | Shanghai Cell Therapy Group 2014, Shanghai (China), Series D | Provider of cell-therapy focused research and development services | $202M | 38/100 | |
10th |  Cell Therapies 2003, Melbourne (Australia), Unfunded | Provider of cell and gene therapy clinical product & testing services | - | - | 37/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Invivyd's competitors? Click here to see the top ones
Invivyd's Investments and acquisitions
Invivyd has made no investments or acquisitions yet.
Reports related to Invivyd
Here is the latest report on Invivyd's geography:
News related to Invivyd
Filter this listMedia has covered Invivyd for a total of 25 events in the last 1 year, 8 of them have been about company updates and 2 about people movement.
•
Invivyd Reports Second Quarter 2026 Financial Results and Recent Business HighlightsGlobeNewswire•Aug 14, 2026•Invivyd
•
•
Invivyd Announces First Participants Dosed in LIBERTY Phase 3 Clinical Trial for VYD2311 AntibodyGlobeNewswire•Jun 09, 2026•Invivyd
•
•
Invivyd Reports Q4 and Full-Year 2025 Financial Results & Business HighlightsGlobeNewswire•Mar 05, 2026•Invivyd
•
•
Invivyd aligns with FDA advice on LIBERTY Phase III Covid-19 trialclinicaltrialsarena.com•Feb 04, 2026•Invivyd
•
Invivyd Partners with Lindsey Vonn to Educate Americans on AntibodiesGlobeNewswire•Jan 22, 2026•Invivyd
•
214,409,450 Common Stock of Invivyd, Inc. are subject to a Lock-Up Agreement Ending on 17-JAN-2026Stock Screener•Jan 17, 2026•Invivyd
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Invivyd
Explore our recently published companies
- Uclaubsbruins - 1981 founded, Unfunded company
- Realtyconsultants - Unfunded company
- Trade Links - Delhi based, 1951 founded, Unfunded company
- SpeedCalcs - Kingston based, 2025 founded, Unfunded company
- Himalaya Wellness Company - Bengaluru based, 1930 founded, Unfunded company
- Jindal Renewables - Gurugram based, 2023 founded, Unfunded company
